#JPM26：Moderna首席执行官班塞尔谈合作、流感与RSV战略
#JPM26: Moderna CEO Bancel talks deals, flu and RSV strategy
生命科学资讯
生物技术与制药领域的最新动态
Moderna寻求反弹，将申请mRNA流感疫苗批准。
Moderna, searching for a rebound, to seek approval of mRNA flu shot
Moderna申请流感疫苗批准；Neumora公布阿尔茨海默病数据
Moderna seeks flu vaccine approvals; Neumora Alzheimer's data
Moderna获资研发H5大流行性流感疫苗
Moderna gets funding for H5 pandemic influenza vaccine
美国卫生与公众服务部资金撤销后，流行病防范创新联盟出资5400万美元支持莫德纳大流行流感疫苗进入三期试验。
After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3
Moderna继续重组，再砍三条研发管线
Moderna's reshaping rolls on with 3 more pipeline purges
#Moderna reshaping#vaccine Spikevax#pipeline purges#infectious diseases#mRNA programs
🚀 Here is the translation of the title to Simplified Chinese: 赛瑞塔公司终止Elevidys试验； Moderna部分pipeline项目被砍 Please note that pre-treatment is not explicitly translated in the title, as it is a concept rather than a specific term.
Sarepta ends Elevidys trial with Hansa's pre-treatment; Some pipeline cuts at Moderna
#Blue Lake#Inhibikase Therapeutics#Olema Oncology#Elevidys trial#Hansa Biopharma
（Modernahù bǎo jiàng 5亿美金 lifeline，瞄准2028年平衡）
Moderna secures $1.5B lifeline as it looks to break even in 2028
#Moderna secures#day event#disease programs#analyst day#invest revenue